A retrospective comparison of organ dose and effective dose in percutaneous vertebroplasty performed under CT guidance or using a fixed C-arm with a flat-panel detector


      • Effective dose was significantly higher for PVP performed under CT guidance.
      • Organ doses were significantly higher with CT-scan than with fixed C-arm, except for oesophagus.
      • From a dosimetry point of view, PVP should preferentially be performed with the fixed C-arm.



      To compare the organ-dose and effective-dose (E) delivered to the patient during percutaneous vertebroplasty (PVP) of one thoracic or lumbar vertebra performed under CT guidance or using a fixed C-arm.


      Consecutive adult patients undergoing PVP of one vertebra under CT-guidance, with optimized protocol and training of physicians, or using a fixed C-arm were retrospectively included from January 2016 to June 2017. Organ-doses were computed on 16 organs using CT Expo 2.4 software for the CT procedures and PCXMC 2.0 for the fixed C-arm procedures. E was also computed with both software. Dosimetric values per anatomic locations for all procedures were compared using the paired Mann-Whitney-Wilcoxon test.


      In total, 73 patients were analysed (27 men and 46 women, mean age 78 ± 10 years) among whom 35 (48%) underwent PVP under CT guidance and 38 (52%) PVP using a fixed C-arm. The median E was 11.31 [6.54; 15.82] mSv for all PVPs performed under CT guidance and 5.58 [3.33; 8.71] mSv for fixed C-arm and the differences was significant (p<0.001). For lumbar PVP, the organ doses of stomach, liver and colon were significantly higher with CT-scan than with the fixed C-arm: 97% (p=0.02); 21% (p=0.099) and 375% (p=0.002), respectively. For thoracic PVP, the lung organ dose was significantly higher with CT-scan than with the fixed C-arm (127%; p<0.001) and the oesophagus organ doses were not significantly different (p = 0.626).


      This study showed that the E and the organ dose on directly exposed organs were both higher for PVP performed under CT-guidance than with the fixed C-arm.


      AK (Air Kerma), CTDIvol (Volume CT dose index), DAP (Dose area product), DLP (Dose length product), E (Effective dose), PVP (Percutaneous vertebroplasty)


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Physica Medica: European Journal of Medical Physics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Anselmetti G.C.
        • Muto M.
        • Guglielmi G.
        • Masala S.
        Percutaneous vertebroplasty or kyphoplasty.
        Radiol Clin North Am. 2010; 48: 641-649
        • Filippiadis D.K.
        • Marcia S.
        • Masala S.
        • Deschamps F.
        • Kelekis A.
        Percutaneous vertebroplasty and kyphoplasty: current status, new developments and old controversies.
        Cardiovasc Intervent Radiol. 2017; 40: 1815-1823
      1. Buchbinder R, Johnston RV, Rischin KJ, Homik J, Jones CA, Golmohammadi K, et al. Percutaneous vertebroplasty for osteoporotic vertebral compression fracture. Cochrane Database Syst Rev. 2018;4:CD006349.

        • Greffier J.
        • Pereira F.R.
        • Viala P.
        • Macri F.
        • Beregi J.-P.
        • Larbi A.
        Interventional spine procedures under CT guidance: how to reduce patient radiation dose without compromising the successful outcome of the procedure?.
        Phys Med. 2017; 35: 88-96
        • Greffier J.
        • Ferretti G.
        • Rousseau J.
        • Andreani O.
        • Alonso E.
        • Rauch A.
        • et al.
        National dose reference levels in computed tomography-guided interventional procedures-a proposal.
        Eur Radiol. 2020; 30: 5690-5701
        • Etard C.
        • Bigand E.
        • Salvat C.
        • Vidal V.
        • Beregi J.P.
        • Hornbeck A.
        • et al.
        Patient dose in interventional radiology: a multicentre study of the most frequent procedures in France.
        Eur Radiol. 2017; 27: 4281-4290
        • Falco M.D.
        • Masala S.
        • Stefanini M.
        • Bagalà P.
        • Morosetti D.
        • Calabria E.
        • et al.
        Effective-dose estimation in interventional radiological procedures.
        Radiol Phys Technol. 2018; 11: 149-155
        • Hwang Y.S.
        • Tsai H.Y.
        • Lin Y.Y.
        • Lui K.W.
        Investigations of organ and effective doses of abdominal cone-beam computed tomography during transarterial chemoembolization using Monte Carlo simulation.
        BMC Med Imag. 2018; 18: 2
        • Xiong Z.
        • Vijayan S.
        • Rudin S.
        • Bednarek D.R.
        Organ and effective dose reduction for region-of-interest (ROI) CBCT and fluoroscopy. Proc SPIE Int Soc.
        Opt Eng. 2017; 10132
      2. Stamm G, Nagel HD. [CT-expo--a novel program for dose evaluation in CT]. Rofo. 2002;174:1570-6.

      3. Tapiovaara M, Siiskonen T. PCXMC: A PC-based Monte Carlo program for calculating patient doses in medical x-ray examinations Second ed: STUK - Radiation and Nuclear Safety Authority; 2008.

      4. International Commission on Radiological Protection - The 2007 Recommendations of the International Commission on Radiological Protection. ICRP Publication 103 Ann ICRP. 2007;37: 1-332.

        • Servomaa A.
        • Tapiovaara M.
        Organ dose calculation in medical X Ray examinations by the program PCXMC.
        Radiat Prot Dosimetry. 1998; 80: 213-219
        • Greffier J.
        • Grussenmeyer-Mary N.
        • Larbi A.
        • Goupil J.
        • Cayla G.
        • Ledermann B.
        • Beregi J.P.
        • Frandon J.
        Experimental evaluation of a radiation dose management system-integrated 3D skin dose map by comparison with XR-RV3 Gafchromic® films.
        Phys Med. 2019; 66: 77-87
        • Greffier J.
        • Grussenmeyer-Mary N.
        • Hamard A.
        • Goupil J.
        • Miller D.E.
        • Cayla G.
        • Ledermann B.
        • Demattei C.
        • Beregi J.P.
        • Frandon J.
        Clinical evaluation of a dose management system-integrated 3D skin dose map by comparison with radiochromic films.
        Eur Radiol. 2020; 30: 5071-5081